| A perspective on oligonucleotide therapy: Approaches to patient customization S Thakur, A Sinhari, P Jain, HR Jadhav Frontiers in Pharmacology 13, 1006304, 2022 | 53 | 2022 |
| Recent efforts for drug identification from phytochemicals against SARS-CoV-2: Exploration of the chemical space to identify druggable leads G Joshi, J Sindhu, S Thakur, A Rana, G Sharma, R Poduri Food and Chemical Toxicology 152, 112160, 2021 | 17 | 2021 |
| Design, synthesis, and pharmacological evaluation of embelin–aryl/alkyl amine hybrids as orally bioavailable blood–brain barrier permeable multitargeted agents with therapeutic … VK Nuthakki, S Choudhary, CN Reddy, S Bhatt, A Jamwal, A Jotshi, ... ACS chemical neuroscience 14 (6), 1193-1219, 2023 | 15 | 2023 |
| Exploring the magic bullets to identify Achilles’ heel in SARS-CoV-2: Delving deeper into the sea of possible therapeutic options in Covid-19 disease: An update S Thakur, B Sarkar, AJ Ansari, A Khandelwal, A Arya, R Poduri, G Joshi Food and Chemical Toxicology 147, 111887, 2021 | 15 | 2021 |
| Current insights toward kidney injury: Decrypting the dual role and mechanism involved of herbal drugs in inducing kidney injury and its treatment TPS Laasya, S Thakur, R Poduri, G Joshi Current Research in Biotechnology 2, 161-175, 2020 | 13 | 2020 |
| Studies on ligand-based pharmacophore modeling approach in identifying potent future EGFR inhibitors GM Shaikh, M Murahari, S Thakur, MS Kumar, YC Mayur Journal of Molecular Graphics and Modelling 112, 108114, 2022 | 10 | 2022 |
| Exploring insights of hydroxychloroquine, a controversial drug in Covid-19: An update G Joshi, S Thakur, R Poduri Food and Chemical Toxicology 151, 112106, 2021 | 9 | 2021 |
| Identification of Azelastine and Carvedilol as Cholinesterase Inhibitors via Structure‐Based Virtual Screening of FDA‐approved Drugs M Sharma, S Thakur, HR Jadhav, SB Bharate ChemistrySelect 8 (28), e202301879, 2023 | 5 | 2023 |
| Discovery of blood-brain barrier permeable and orally bioavailable caffeine-based amide derivatives as acetylcholinesterase inhibitors M Sharma, A Sharma, S Thakur, VK Nuthakki, A Jamwal, U Nandi, ... Bioorganic Chemistry 139, 106719, 2023 | 4 | 2023 |
| Methoxy-naphthyl-Linked N-Benzyl Pyridinium Styryls as Dual Cholinesterase Inhibitors: Design, Synthesis, Biological Evaluation, and Structure–Activity Relationship M Abdullaha, R Banoo, VK Nuthakki, M Sharma, S Kaur, S Thakur, ... ACS omega 8 (20), 17591-17608, 2023 | 2 | 2023 |
| FDA approved fused pyrimidine-based drugs S Thakur, AJ Ansari, G Joshi Fused Pyrimidine-Based Drug Discovery, 13-38, 2023 | 2 | 2023 |
| FDA approved fused-pyrimidines as potential PI3K inhibitors: a computational repurposing approach P Vishwakarma, NF Siddiqui, S Thakur, H Jadhav Journal of Biomolecular Structure and Dynamics, 1-18, 2023 | 1 | 2023 |
| Design and Efficient Synthesis of New 4-Amino-Substituted 2-(4-Bromobenzyl)-5, 6, 7, 8-tetrahydrobenzo [4, 5] thieno [2, 3-d] pyrimidines of Anticancer Interest and Their In … S Arora, S Thakur, VR Kaki, R Kumar Synthesis, 2024 | | 2024 |
| Fused Thienopyrimidines as Versatile Pharmacophores for the Development of Cyclooxygenase‐2 Inhibitors S Thakur, S Arora, MK Katiyar, G Joshi, R Kumar ChemistrySelect 9 (22), e202400514, 2024 | | 2024 |
| A structure-based pharmacophore modelling approach to identify and design new neprilysin (NEP) inhibitors: An in silico-based investigation S Thakur, A Sinhari, AB Gaikwad, HR Jadhav Archives of Biochemistry and Biophysics 756, 110019, 2024 | | 2024 |
| Bioactivity predictions and virtual screening using machine learning predictive model NF Siddiqui, P Vishwakarma, S Thakur, HR Jadhav Journal of Biomolecular Structure and Dynamics, 1-20, 2024 | | 2024 |
| Investigation of antibacterial potential of Natsiatum herpeticum Buch.-Ham. ex Arn. using in silico-in vitro approach S Hazarika, S Thakur, HR Jadhav, P Chetia, D Laloo, S Hemalatha South African Journal of Botany 164, 167-179, 2024 | | 2024 |
Gaurav JoshiHemvati Nandan Bahuguna Garhwal (A Central) University在 hnbgu.ac.in 的电子邮件经过验证
